ARTELO BIOSCIENCES, INC. Increase (Decrease) in Other Current Assets
ARTELO BIOSCIENCES, INC. (ARTL) reported Increase (Decrease) in Other Current Assets of $20.77 thousand for the 6-month period ending 2020-02-29, per its 10-Q filed 2020-04-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2020-04-13
- ARTELO BIOSCIENCES, INC. increase (decrease) in other current assets for the quarter ending 2020-02-29 was -$16.03K, a 392.02% decline year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other current assets for the quarter ending 2019-11-30 was $36.80K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other current assets for the quarter ending 2019-05-31 was -$2.01K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in other current assets for the quarter ending 2019-02-28 was $5.49K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month |
|---|---|---|---|
| 2020-02-29 | -$16.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $20.77K 10-Q · filed 2020-04-13 | |
| 2019-11-30 | $36.80K 10-Q · filed 2020-01-14 | ||
| 2019-05-31 | -$2.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-15 | $3.48K derived: sum of 2 quarters · filed 2020-04-13 | -$15.19K 10-Q · filed 2019-07-15 |
| 2019-02-28 | $5.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | -$13.18K 10-Q · filed 2020-04-13 | |
| 2018-11-30 | -$18.66K 10-Q · filed 2020-01-14 | ||
| 2018-05-31 | $16.48K 10-Q · filed 2019-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |